Hofseth Biocare ASA Net Assets

Latest as of September 2025: Nkr-27.85 Million NOK ≈ $-2.93 Million USD

Hofseth Biocare ASA net assets. Based on the latest financial reports, Hofseth Biocare ASA (HBC) has net assets worth Nkr-27.85 Million NOK (≈ $-2.93 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Nkr391.35 Million ≈ $41.18 Million USD) and total liabilities (Nkr419.19 Million ≈ $44.11 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore Hofseth Biocare ASA (HBC) net asset momentum to track the company's year-over-year net asset growth rate.

Key Net Assets Metrics

Metric	Value
Current Net Assets	Nkr-27.85 Million
% of Total Assets	-7.12%
Annual Growth Rate	-1.52%
5-Year Change	-76.76%
10-Year Change	88.36%
Growth Volatility	63.54

Net Assets of Hofseth Biocare ASA (2010–2024)

Net assets of Hofseth Biocare ASA from 2010 to 2024. This chart illustrates how Hofseth Biocare ASA's net assets have evolved over time, based on quarterly financial data. See how leveraged is Hofseth Biocare ASA's balance sheet to measure how much of total assets are equity-financed.

Annual Net Assets for Hofseth Biocare ASA (2010–2024)

The table below shows the annual net assets of Hofseth Biocare ASA from 2010 to 2024. For live market cap and overall valuation, see HBC market cap.

Year	Net Assets	Change
2024-12-31	Nkr61.30 Million ≈ $6.45 Million	+49.01%
2023-12-31	Nkr41.14 Million ≈ $4.33 Million	-72.21%
2022-12-31	Nkr148.03 Million ≈ $15.58 Million	+5.45%
2021-12-31	Nkr140.38 Million ≈ $14.77 Million	-46.78%
2020-12-31	Nkr263.76 Million ≈ $27.76 Million	+124.00%
2019-12-31	Nkr117.75 Million ≈ $12.39 Million	+36.85%
2018-12-31	Nkr86.04 Million ≈ $9.05 Million	+132.03%
2017-12-31	Nkr37.08 Million ≈ $3.90 Million	-30.77%
2016-12-31	Nkr53.56 Million ≈ $5.64 Million	+64.58%
2015-12-31	Nkr32.55 Million ≈ $3.42 Million	-58.78%
2014-12-31	Nkr78.95 Million ≈ $8.31 Million	+27.33%
2013-12-31	Nkr62.00 Million ≈ $6.52 Million	+29.94%
2012-12-31	Nkr47.72 Million ≈ $5.02 Million	-60.41%
2011-12-31	Nkr120.53 Million ≈ $12.68 Million	+58.66%
2010-12-31	Nkr75.97 Million ≈ $7.99 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Hofseth Biocare ASA's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 1013500000.0% over the analyzed period, indicating profitable operations and earnings retention.

Hofseth Biocare ASA Net Assets Breakdown (December 2024)

Hofseth Biocare ASA net assets breakdown by equity component as of December 2024.

Component	Amount	Percentage
Common Stock	Nkr4.11 Million	6.85%
Other Components	Nkr55.93 Million	93.15%
Total Equity	Nkr60.05 Million	100.00%

Hofseth Biocare ASA Competitors by Market Cap

The table below lists competitors of Hofseth Biocare ASA ranked by their market capitalization.

Company	Market Cap
Nevada King Gold Corp V:NKG	$45.74 Million
Asia Pacific Wire & Cable Corp Ltd NASDAQ:APWC	$45.77 Million
Kentucky First Federal Bancorp NASDAQ:KFFB	$45.77 Million
LAVA Therapeutics NV NASDAQ:LVTX	$45.77 Million
Spectral AI Inc. NASDAQ:MDAI	$45.73 Million
Primotec Group Ltd TA:PRMG	$45.72 Million
YES24 Co.Ltd KQ:053280	$45.72 Million
Li Cheng Enterprise Co Ltd TW:4426	$45.70 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Hofseth Biocare ASA's equity between the two most recent reporting periods.

Equity Growth Insights

From 2023 to 2024, total equity changed from 41,827,000 to 60,045,000, a change of 18,218,000 (43.6%).
Net loss of 123,405,000 reduced equity.
Other factors increased equity by 141,623,000.

Equity Change Factors (2023 to 2024)

Factor	Impact	Contribution
Net Income	Nkr-123.41 Million	-205.52%
Other Changes	Nkr141.62 Million	+235.86%
Total Change	Nkr-	43.56%

Book Value vs Market Value Analysis

This analysis compares Hofseth Biocare ASA's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 7.55x
The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
The price-to-book ratio has increased from 0.41x to 7.55x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2010-12-31	Nkr2.67	Nkr1.10	x
2011-12-31	Nkr2.73	Nkr1.10	x
2012-12-31	Nkr0.82	Nkr1.10	x
2013-12-31	Nkr0.84	Nkr1.10	x
2014-12-31	Nkr0.86	Nkr1.10	x
2015-12-31	Nkr0.31	Nkr1.10	x
2016-12-31	Nkr0.37	Nkr1.10	x
2017-12-31	Nkr0.16	Nkr1.10	x
2018-12-31	Nkr0.33	Nkr1.10	x
2019-12-31	Nkr0.39	Nkr1.10	x
2020-12-31	Nkr0.79	Nkr1.10	x
2021-12-31	Nkr0.39	Nkr1.10	x
2022-12-31	Nkr0.40	Nkr1.10	x
2023-12-31	Nkr0.11	Nkr1.10	x
2024-12-31	Nkr0.15	Nkr1.10	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Hofseth Biocare ASA utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): -205.52%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: -47.94%
• Asset Turnover: 0.75x
• Equity Multiplier: 5.69x
Recent ROE (-205.52%) is below the historical average (-121.34%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2010	-12.36%	-5489.47%	0.00x	1.24x	Nkr-16.98 Million
2011	-15.80%	-1609.13%	0.01x	1.31x	Nkr-31.08 Million
2012	-152.90%	-283.91%	0.17x	3.22x	Nkr-78.69 Million
2013	-83.26%	-82.84%	0.31x	3.27x	Nkr-58.40 Million
2014	-84.08%	-338.50%	0.09x	2.74x	Nkr-74.88 Million
2015	-301.84%	-181.72%	0.29x	5.82x	Nkr-103.51 Million
2016	-271.94%	-729.81%	0.13x	2.94x	Nkr-152.87 Million
2017	-43.64%	-13.91%	0.64x	4.88x	Nkr-20.25 Million
2018	-97.75%	-139.56%	0.32x	2.17x	Nkr-93.44 Million
2019	-75.33%	-131.62%	0.23x	2.47x	Nkr-101.05 Million
2020	-38.60%	-147.42%	0.15x	1.74x	Nkr-128.53 Million
2021	-89.65%	-144.34%	0.21x	2.95x	Nkr-140.57 Million
2022	-92.38%	-114.06%	0.29x	2.76x	Nkr-152.26 Million
2023	-255.06%	-54.74%	0.50x	9.33x	Nkr-110.87 Million
2024	-205.52%	-47.94%	0.75x	5.69x	Nkr-129.41 Million

Industry Comparison

This section compares Hofseth Biocare ASA's net assets metrics with peer companies in the Packaged Foods industry.

Industry Context

Industry: Packaged Foods
Average net assets among peers: $5,270,285,000
Average return on equity (ROE) among peers: 43.69%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Hofseth Biocare ASA (HBC)	Nkr-27.85 Million	-12.36%	N/A	$45.73 Million
Aker Biomarine AS (AKBM)	$173.90 Million	104.89%	1.23x	$1.13 Billion
Lerøy Seafood Group ASA (LSG)	$5.96 Billion	8.06%	0.97x	$2.68 Billion
Orkla ASA (ORK)	$9.67 Billion	18.11%	1.74x	$10.38 Billion

About Hofseth Biocare ASA

OL:HBC Norway Packaged Foods

Market Cap

$45.73 Million

Nkr434.58 Million NOK

Market Cap Rank

#21987 Global

#201 in Norway

Share Price

Nkr1.10

Change (1 day)

+0.92%

52-Week Range

Nkr1.09 - Nkr1.90

All Time High

Nkr10.95